Modern Soft Tissue Pathology: PARAGANGLIOMAS

[1]  R. Seyam,et al.  The clinical spectrum of phaeochromocytoma: analysis of 115 patients , 2008, BJU international.

[2]  Steven D Chang,et al.  Radiosurgery for Glomus Jugulare Tumors , 2007, Technology in cancer research & treatment.

[3]  G. Arnaldi,et al.  Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  W. Kaelin,et al.  Von Hippel-Lindau disease. , 2007, Annual review of pathology.

[5]  H. Neumann,et al.  Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. , 2006, The New England journal of medicine.

[6]  Peter Devilee,et al.  Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma , 2006, BMC Medical Genetics.

[7]  S. Suster,et al.  Sclerosing Paraganglioma: Report of 19 Cases of an Unusual Variant of Neuroendocrine Tumor That May Be Mistaken for an Aggressive Malignant Neoplasm , 2006, The American journal of surgical pathology.

[8]  C. Eng,et al.  Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. , 2005, JAMA.

[9]  H. Neumann,et al.  Genetic testing for pheochromocytoma-associated syndromes. , 2005, Annales d'endocrinologie.

[10]  D. Marsh,et al.  Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas , 2003, Oncogene.

[11]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[12]  A. Munnich,et al.  Succinate dehydrogenase and human diseases: new insights into a well-known enzyme , 2002, European Journal of Human Genetics.

[13]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[14]  W. Rubinstein,et al.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.

[15]  L. Karnell,et al.  National Cancer Data Base report on malignant paragangliomas of the head and neck , 2002, Cancer.

[16]  P. Heikkilä,et al.  Increased Expression of Tenascin in Pheochromocytomas Correlates With Malignancy , 2001, The American journal of surgical pathology.

[17]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[18]  C. A. Friedrich.  Genotype-phenotype correlation in von Hippel-Lindau syndrome. , 2001, Human molecular genetics.

[19]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[20]  H. Bonjer,et al.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. , 2000, The American journal of pathology.

[21]  G. Mortier,et al.  Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene , 2000, Human Genetics.

[22]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[23]  C. Larsson,et al.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. , 2000, The American journal of pathology.

[24]  H. Kato,et al.  Clinicopathological study of pheochromocytoma of the urinary bladder: Immunohistochemical, flow cytometric and ultrastructural findings with review of the literature , 1999, Pathology international.

[25]  J. Carney,et al.  Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. , 1999, Mayo Clinic proceedings.

[26]  J. Netterville,et al.  Vagal paraganglioma: a review of 46 patients treated during a 20-year period. , 1998, Archives of otolaryngology--head & neck surgery.

[27]  M. Bar,et al.  Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel‐Lindau and RET genes , 1997, Clinical endocrinology.

[28]  C. Moran,et al.  Primary spinal paragangliomas: a clinicopathological and immunohistochemical study of 30 cases , 1997, Histopathology.

[29]  C. Healey,et al.  Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. , 1994, Human molecular genetics.

[30]  R. Hofstra,et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.

[31]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[32]  G. Finkel,et al.  Recurrent duodenal gangliocytic paraganglioma with lymph node metastases , 1993, Histopathology.

[33]  T. Molina,et al.  Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies. , 1991, Human pathology.

[34]  G. Klöppel,et al.  Immunocytochemistry of paragangliomas—value of staining for S‐100 protein and glial fibrillary acid protein in diagnosis and prognosis , 1991, Histopathology.

[35]  S. Steinberg,et al.  Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. , 1990, Human pathology.

[36]  L. Peters,et al.  Paragangliomas of the head and neck. , 1988, Archives of otolaryngology--head & neck surgery.

[37]  P. Pairolero,et al.  Surgical resection of carotid body tumors: long-term survival, recurrence, and metastasis. , 1988, Mayo Clinic proceedings.

[38]  B. Scheithauer,et al.  Duodenal gangliocytic paraganglioma. Clinicopathologic and immunocytochemical study of 11 cases. , 1986, American journal of clinical pathology.

[39]  J. Polak,et al.  Duodenal gangliocytic paragangliomas: a study of 10 cases with immunocytochemical neuroendocrine markers. , 1986, Human pathology.

[40]  M. Orringer,et al.  Cardiac paragangliomas: A clinicopathologic and immunohistochemical study of four cases , 1985, The American journal of surgical pathology.

[41]  W. Bell,et al.  Metastatic intravagal paraganglioma. Case report and review of the literature. , 1985, The American journal of medicine.

[42]  L. Medeiros,et al.  Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. , 1985, Human pathology.

[43]  James S. Brown.  Glomus jugulare tumors revisited: A ten‐year statistical follow‐up of 231 cases , 1985, The Laryngoscope.

[44]  J. Rosai,et al.  Duodenal gangliocytic paraganglioma: An immunohistochemical and ultrastructural study and a hypothesis concerning its origin , 1985, The American journal of surgical pathology.

[45]  J. Woodruff,et al.  Extra-adrenal paragangliomas of the retroperitoneum: A clinicopathologic study of 12 tumors , 1980, The American journal of surgical pathology.

[46]  S. Sheps,et al.  Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2 , 1980, The American journal of surgical pathology.

[47]  J. Woodruff,et al.  Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients. , 1979, Human pathology.

[48]  J. Arias-Stella,et al.  Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance. , 1976, Human pathology.

[49]  M. Saldana,et al.  High altitude hypoxia and chemodectomas. , 1973, Human pathology.

[50]  S. Sheps,et al.  Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. , 1971, American journal of surgery.

[51]  J. Ellison,et al.  Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.

[52]  W. Kaelin,et al.  Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma , 2006, Endocrine pathology.

[53]  F. Mantero,et al.  Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1 , 2004, Familial Cancer.

[54]  E. Mariman,et al.  Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity , 2004, Human Genetics.

[55]  A. Vortmeyer,et al.  Pheochromocytoma in von hippel-lindau disease: Distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2 , 2002, Endocrine pathology.

[56]  C. Eng.  RET proto-oncogene in the development of human cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  A. Cochran,et al.  Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. , 1989, Human pathology.

[58]  S. Steinberg,et al.  Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. , 1988, Human pathology.

[59]  W. Warren,et al.  Paragangliomas of the head and neck: ultrastructural and immunohistochemical analysis. , 1985, Ultrastructural pathology.